Semaglutide is a GLP-1 analogue with an Aib (2-amino isobutyric acid) in position 2 and a C18 chain linked to K20 through a small PEG spacer which was accepted by the FDA in 2018 for the treatment of diabetes as a once weekly treatment and is presently in phase 3 clinical trial for a once daily oral treatment 50,51
Weight-loss management at RVA Regenerative Wellness takes an individualized and holistic approach
Both patients and doctors need to understand that these drugs also lower cardiovascular disease outcomes that may be even more important than their weight loss effects since cardiovascular disease is the leading cause of death for persons with diabetes or overweight/obesity (evidence already published for Ozempic showing reduction in cardiovascular events, pending for Wegovy and clinical trials are ongoing for Mounjaro). Type 2 diabetes can be managed
[4] Certain amino acids , such as tyrosine, are required to make thyroid hormones
Night-Time Effectiveness (Suitable for some) In circadian biology, the body's own detoxification and cellular repair are most active during the night
Sleep quality improvement Obesity is strongly associated with obstructive sleep apnea (OSA), a condition that fragments sleep and causes intermittent hypoxia throughout the night